Skip to Main Content

This year’s Summit will feature expert voices from the FDA, leading pharmaceutical companies and other industry stakeholders

BOSTON, MA – STAT, the nation’s must-read health, science, and medicine publication, recently announced that its inaugural 2021 STAT Breakthrough Science Summit will take place July 13-14. After a year that forced to innovation at unprecedented speed, the Summit will convene critical discussions about the latest discoveries in medicine and the next leaps in innovation

The Summit will give its guests exclusive insights into the technologies and treatments that were once science fiction and are now the reality of medicine , gathering leading experts to discuss  how these advances will be developed, adopted, and paid for. The event will also look at the breakthroughs that have yet to hit the market but have the potential to redefine health and medicine in the years to come. 

The Summit will explore innovations in areas such as mRNA technology, the future of gene therapy, cancer immunotherapy, and what’s next in the battle against COVID. Programming will begin at 1:00 p.m. ET each day, and will feature experts working directly with these innovations, including: 

  • Janet Woodcock, M.D., Acting Commissioner of the U.S. FDA
  • Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health
  • Ugur Sahin, M.D., Co-Founder and CEO, BioNTech
  • David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly
  • Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research and Development, Pfizer
  • Sekar Kathiresan, M.D., CEO, Verve Therapeutics
  • Katherine High, M.D., President, Therapeutics, AskBio
  • Bobby Gaspar, M.D., Ph.D., Chief Executive Officer and Co-Founder, Orchard Therapeutics
  • Anne Wojcicki, Co-Founder and CEO, 23andMe
  • Katalin Karikó, Ph.D., Senior Vice President, BioNTech SE; Adjunct Associate Professor, Perelman School of Medicine, University of Pennsylvania
  • David R. Liu, Ph.D., Vice-Chair and Core Faculty Member of the Broad Institute; Professor of Chemistry and Chemical Biology at Harvard University; HHMI Investigator
  • James P. Allison, Ph.D., Regental Professor and Chair of Immunology at The University of Texas MD Anderson Cancer Center
  • Robert Nelsen, Co-founder and Managing Director, ARCH Venture Partners
  • Uché Blackstock, M.D., Founder and CEO, Advancing Health Equity
  • Sammy Basso, Spokesperson for The Progeria Research Foundation and The Sammy Basso Italian Association for Progeria

STAT will be announcing additional speakers in the coming weeks.

“Rigorously covering the rapid pace of scientific advancement in biology and medicine is at the center of what we do every day at STAT,” said Matthew Herper, STAT Senior Writer, Medicine and Editorial Director, Events. “This new summit provides us an opportunity to gather speakers and attendees who are central to the research enterprise, and to start conversations that will help us understand what’s happened so far in this difficult year and to be ready to grasp what’s next.”

“We are at an inflection point in drug discovery and development, with the convergence of advances in biology, chemistry, data, computation and novel modalities,” said Sara Kenkare-Mitra, Ph.D., Senior Vice President, Development Sciences, Genentech, a member of the Roche Group, the 2021 STAT Breakthrough Science Summit Presenting Sponsor. “There has never been a more important time to invest in scientific innovation, and we’re pleased to be a part of this summit that will bring together the diverse perspectives and expertise needed to tackle the biggest questions in medicine and catalyze future breakthroughs for patients.”


Founded in 2015, STAT is a national digital media brand that focuses on delivering fast, deep, and tough-minded journalism about the life sciences industries to over six million monthly site visitors and an additional 20 million readers on the Apple News app. STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye on scientific discoveries, scrutinizing corporate strategies, and chronicling the roiling battles for talent, money, and market share. With an award-winning newsroom, STAT provides indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life sciences industry — and a revolution in human health.

STAT’s main newsroom is located in Boston, with bureaus in Washington, New York City, Cleveland, San Francisco, and Los Angeles.